Fundamentals Overview
Eastman Chemical Company is in the middle of its 52-week range with moderate valuation, trading relatively flat today.
Valuation moderate
Intrinsic value (DCF)
+21.4% upside vs price
Profitability
Risk (Beta)
1.17 — in line vol
Earnings & growth
BullzEye Analysis
Our composite tilts Hold on technicals (e.g. RSI, ADX, trend), fundamentals, sentiment, sector and index context, and risk.
Composite Signal
Supporting (Buy):
DCF +21.4% upside vs price · Analyst grade: B+
Pressures (Sell):
Sentiment weakening (2 downgrades)
Not financial advice. For education and research only; do your own research and consider a financial advisor before investing.
Key Stats
About
Ratings & Grades at a Glance
Overall rating: B+. Recent institutional grades: majority downgrades. Current institutional positions: Buy: 13, Equal Weight: 1, Hold: 1, In Line: 2, Neutral: 2, Outperform: 3, Overweight: 7, Sector Perform: 1.
Valuation & Ratios
Valuation, liquidity, and profitability metrics are consolidated here (including ratios that previously appeared in the Financials story). Trailing (TTM) vs forward-looking (e.g. DCF) is noted on each line where it matters.
DCF vs price: DCF estimate is $88.04; current price is $72.52. That’s a +21.4% gap. When the gap is large (e.g. >20%), that’s divergence; when they’re close, that’s convergence. Differences can reflect growth expectations, sector premiums, or conservative vs. optimistic assumptions. Use DCF as one input alongside technicals and sentiment.
| Metric | Value |
|---|---|
| Valuation | |
| P/E (TTM) | 17.58 |
| DCF value (model) | $88.04 (21.4% upside) |
| PEG (TTM) | N/A |
| P/B (TTM) | 1.39 |
| P/S (TTM) | 0.95 |
| P/FCF (TTM) | 19.56 |
| Liquidity & enterprise | |
| Current Ratio (TTM) | 1.37 |
| Quick Ratio (TTM) | 0.63 |
| Cash Ratio (TTM) | 0.21 |
| Profitability | |
| ROE (TTM) | N/A |
| ROA (TTM) | N/A |
| Revenue growth (YoY) | N/A |
| Net margin (TTM) | 5.42% |
| Gross margin (TTM) | 21.07% |
| Operating margin (TTM) | 10.66% |
| Debt to equity (TTM) | N/A |
Latest News
News loads when you open this tab.
Price Target, Ratings & Grades
Analyst price targets, consensus, rating snapshot, and institutional grades for EMN.
Analyst Sentiment at a Glance
Stock Grades (Institutions)
| Institution | Action | Previous Grade | New Grade | Date |
|---|---|---|---|---|
| Citigroup | maintain | Buy | Buy | 2026-04-16 |
| JP Morgan | upgrade | Neutral | Overweight | 2026-04-14 |
| UBS | maintain | Buy | Buy | 2026-04-09 |
| Citigroup | maintain | Buy | Buy | 2026-03-12 |
| Evercore ISI Group | maintain | In Line | In Line | 2026-02-18 |
| Citigroup | maintain | Buy | Buy | 2026-02-03 |
| B of A Securities | maintain | Buy | Buy | 2026-02-02 |
| JP Morgan | maintain | Neutral | Neutral | 2026-02-02 |
| Deutsche Bank | maintain | Hold | Hold | 2026-02-02 |
| RBC Capital | downgrade | Outperform | Sector Perform | 2026-01-16 |
| Citigroup | maintain | Buy | Buy | 2026-01-15 |
| Keybanc | maintain | Overweight | Overweight | 2026-01-09 |
| Wells Fargo | downgrade | Overweight | Equal Weight | 2025-12-19 |
| Citigroup | maintain | Buy | Buy | 2025-12-18 |
| Evercore ISI Group | maintain | In Line | In Line | 2025-11-11 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-11-05 |
| UBS | maintain | Buy | Buy | 2025-11-05 |
| UBS | maintain | Buy | Buy | 2025-11-01 |
| B of A Securities | maintain | Buy | Buy | 2025-10-14 |
| UBS | maintain | Buy | Buy | 2025-10-06 |
| Mizuho | maintain | Outperform | Outperform | 2025-10-03 |
| Citigroup | maintain | Buy | Buy | 2025-10-02 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-09-16 |
| Goldman Sachs | maintain | Neutral | Neutral | 2025-08-07 |
| RBC Capital | maintain | Outperform | Outperform | 2025-08-05 |
| Wells Fargo | maintain | Overweight | Overweight | 2025-08-04 |
| Keybanc | maintain | Overweight | Overweight | 2025-08-04 |
| Citigroup | maintain | Buy | Buy | 2025-08-04 |
| Mizuho | maintain | Outperform | Outperform | 2025-08-01 |
| Keybanc | maintain | Overweight | Overweight | 2025-07-14 |